CAMP4 Therapeutics, a clinical-stage biopharmaceutical company focused on RNA-targeting therapeutics, will participate in a panel at Chardan’s 10th Annual Healthcare Conference on October 20, 2026. The panel will discuss RNA medicines and transcriptome engineering, highlighting CAMP4’s approach to amplifying mRNA to treat genetic diseases. The event will be webcast and available on CAMP4’s investor relations website. This participation underscores CAMP4’s ongoing efforts to advance its pipeline of treatments for genetic disorders by targeting regulatory RNAs to increase healthy protein levels.
CAMP4 Therapeutics is participating in Chardan’s 10th Annual Healthcare Conference. For readers following the health sector, here is Pluang's market snapshot as of Oct 14, 2026 19:01 WIB: out of 150 priced US health stocks, 105 rose and 40 fell today. Notable movers include ClearPoint Neuro Inc (CLPT) at USD 10.14 with a 3.36% increase and 100% buy order activity, Guardant Health Inc (GH) at USD 158.20 down 2.40% but also with 100% buy order activity, and DENTSPLY SIRONA Inc (XRAY) at USD 8.69 up 2.18%. Typical hold times vary from 3 to 72 days on Pluang.
Genesis Global won the Best AI Solution for Software Development award at the 2026 AI in Capital Markets Awards for its product Genesis Create. This software combines AI with reusable components and financial expertise to help firms develop productio...
nuVizz has been recognized as an Accelerator in the 2026 Nucleus Research Transportation Management Value Matrix for its specialized last-mile delivery technology. The platform excels in coordinating complex delivery networks involving private fleets...
ASML Holding posted a strong Q3 2026 earnings per share of $14.65, beating estimates of $12.17, driven by a 55% year-over-year sales growth and a 57.5% gross margin. Although revenue was slightly below expectations at $13.05 billion, the company bene...
Charles Schwab is set to report its Q3 2026 earnings with an estimated EPS of $1.66 and revenue around $7.18-$7.19 billion, reflecting significant growth driven by an 18.2% increase in trading revenue, net interest income, and asset management fees. ...
Transmission System Operators (TSOs) are increasingly investing in software like Energy Management Systems and grid planning tools to modernize aging infrastructure, enhance cybersecurity, and expand grid capacity. Cybersecurity remains their top con...
